|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0007131,
umls-concept:C0017262,
umls-concept:C0025723,
umls-concept:C0026882,
umls-concept:C0033325,
umls-concept:C0034802,
umls-concept:C0185117,
umls-concept:C2826293,
umls-concept:C2911684,
umls-concept:C2936365
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-9-15
|
|
pubmed:abstractText |
The expression of prostaglandin E receptor 2 (PTGER2) affects the biologic behavior of various types of malignant tumors. Recently, transactivation of both PTGER2 and epidermal growth factor receptor (EGFR) has been reported in some tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/PTGER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, EP2...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:FujisawaTakehikoT,
pubmed-author:HiroshimaKenzoK,
pubmed-author:KuboRiekoR,
pubmed-author:NakajimaTakahiroT,
pubmed-author:NakataniYukioY,
pubmed-author:SOGADD,
pubmed-author:SekineYasuoY,
pubmed-author:ShibuyaKiyoshiK,
pubmed-author:SuzukiMakotoM,
pubmed-author:YoshinoIchiroI,
pubmed-author:and the Thoracic Surgery Group
|
|
pubmed:copyrightInfo |
(c) 2008 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1396-403
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18666211-Adenocarcinoma,
pubmed-meshheading:18666211-Aged,
pubmed-meshheading:18666211-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18666211-DNA Methylation,
pubmed-meshheading:18666211-Female,
pubmed-meshheading:18666211-Humans,
pubmed-meshheading:18666211-Lung Neoplasms,
pubmed-meshheading:18666211-Male,
pubmed-meshheading:18666211-Mutation,
pubmed-meshheading:18666211-Prognosis,
pubmed-meshheading:18666211-RNA, Messenger,
pubmed-meshheading:18666211-RNA, Neoplasm,
pubmed-meshheading:18666211-Receptor, Epidermal Growth Factor,
pubmed-meshheading:18666211-Receptors, Prostaglandin E,
pubmed-meshheading:18666211-Receptors, Prostaglandin E, EP2 Subtype,
pubmed-meshheading:18666211-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18666211-Survival Rate,
pubmed-meshheading:18666211-Tumor Cells, Cultured,
pubmed-meshheading:18666211-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation.
|
|
pubmed:affiliation |
Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
